These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 6127273)

  • 1. Effect of somatostatin on fasting and glucose-stimulated gastric inhibitory polypeptide release in man.
    Salera M; Pironi L; Giacomoni P; Venturi S; Capelli M; Miglioli M; Barbara L
    Digestion; 1982; 24(2):126-32. PubMed ID: 6127273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lowering of fasting and food stimulated serum immunoreactive gastric inhibitory polypeptide (GIP) by glucagon.
    Ebert R; Arnold R; Creutzfeldt W
    Gut; 1977 Feb; 18(2):121-7. PubMed ID: 856672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastric emptying and release of incretin hormones after glucose ingestion in humans.
    Schirra J; Katschinski M; Weidmann C; Schäfer T; Wank U; Arnold R; Göke B
    J Clin Invest; 1996 Jan; 97(1):92-103. PubMed ID: 8550855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of somatostatin on glucose-induced release of gastric inhibitory polypeptide in rats.
    Ho LT; Pu HF; Sheu WJ; Wang WC; Wang PS
    Chin J Physiol; 1987; 30(2):45-53. PubMed ID: 2896583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of somatostatin on release and insulinotropic action of gastric inhibitory polypeptide.
    Pederson RA; Dryburgh JR; Brown JC
    Can J Physiol Pharmacol; 1975 Dec; 53(6):1200-5. PubMed ID: 1222389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adrenergic modulation of gastric inhibitory polypeptide secretion in man.
    Salera M; Ebert R; Giacomoni P; Pironi L; Venturi S; Corinaldesi R; Miglioli M; Barbara L
    Dig Dis Sci; 1982 Sep; 27(9):794-800. PubMed ID: 7049625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of calcium on the release of gastric inhibitory polypeptide (GIP) - with reference to the release of GIP in patients with hyperparathyroidism (author's transl)].
    Nakanome C; Akai H; Umezu M; Toyota T; Goto Y; Furukawa Y; Sato T; Yumita S; Bloom SR
    Nihon Naibunpi Gakkai Zasshi; 1982 Feb; 58(2):98-109. PubMed ID: 7044844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of endogenous somatostatin, gastric inhibitory polypeptide, glucagon and insulin with gastric function in the conscious calf.
    Bell FR; Webber DE; Wass JA; Rees LH; Evans J; Morgan LM; Marks V; Lewis J
    J Endocrinol; 1981 Jun; 89(3):451-6. PubMed ID: 6114125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of somatostatin on fasting and postprandial plasma GIP, serum insulin, and blood glucose in man.
    Jorde R; Waldum HL; Burhol PG; Lygren I; Schulz TB; Florholmen J; Jenssen TG
    Scand J Gastroenterol; 1981; 16(1):113-9. PubMed ID: 6112787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastric inhibitory polypeptide and insulin release in response to oral and intravenous glucose in coeliac disease.
    Lauritsen KB; Lauritzen JB; Christensen KC
    Scand J Gastroenterol; 1982 Mar; 17(2):241-5. PubMed ID: 6753103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of intravenous somatostatin and motilin on the blood glucose and hormonal response to oral glucose.
    Long RG; Christofides ND; Fitzpatrick ML; O'Shaughnessy DJ; Bloom SR
    Eur J Clin Invest; 1982 Aug; 12(4):331-6. PubMed ID: 6128230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastric inhibitory polypeptide (GIP) and insulin release in duodenal ulcer patients.
    Cataland S; O'Dorisio TM; Crockett SE; Mekhjian HS
    J Clin Endocrinol Metab; 1978 Sep; 47(3):615-9. PubMed ID: 400727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral glucose augmentation of insulin secretion. Interactions of gastric inhibitory polypeptide with ambient glucose and insulin levels.
    Andersen DK; Elahi D; Brown JC; Tobin JD; Andres R
    J Clin Invest; 1978 Jul; 62(1):152-61. PubMed ID: 659629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of oral galactose on GIP and insulin secretion in man.
    Morgan LM; Wright JW; Marks V
    Diabetologia; 1979 Apr; 16(4):235-9. PubMed ID: 428694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of glucagon, gastric inhibitory polypeptide, pancreatic polypeptide and somatostatin on beta-adrenergically induced insulin secretion in the mouse.
    Ahrén B; Lundquist I
    Diabete Metab; 1982 Sep; 8(3):209-12. PubMed ID: 6128264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Xylitol vs glucose: effect on the rate of gastric emptying and motilin, insulin, and gastric inhibitory polypeptide release.
    Salminen EK; Salminen SJ; Porkka L; Kwasowski P; Marks V; Koivistoinen PE
    Am J Clin Nutr; 1989 Jun; 49(6):1228-32. PubMed ID: 2658536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Release of gastric inhibitory polypeptide (GIP) during calcium infusion and in hyperparathyroidism.
    Toyota T; Nakanome C; Akai H; Umezu M; Goto Y
    Regul Pept; 1982 Jun; 4(1):1-12. PubMed ID: 6750703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of fat-stimulated gastric inhibitory polypeptide on pancreatic alpha and beta cell function.
    Verdonk CA; Rizza RA; Nelson RL; Go VL; Gerich JE; Service FJ
    J Clin Invest; 1980 May; 65(5):1119-25. PubMed ID: 6988457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of gastric inhibitory polypeptide (GIP) release by insulin and glucose in juvenile diabetes.
    Creutzfeldt W; Talaulicar M; Ebert R; Willms B
    Diabetes; 1980 Feb; 29(2):140-5. PubMed ID: 6986299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum gastric inhibitory polypeptide (GIP) in duodenal ulcer disease: relationship to glucose tolerance, insulin, and gastrin release.
    Arnold R; Creutzfeldt W; Ebert R; Becker HD; Börger HW; Schafmayer A
    Scand J Gastroenterol; 1978; 13(1):41-7. PubMed ID: 635445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.